CRESCENT BIOPHARMA, INC. Shares Outstanding

Quick Answer

CRESCENT BIOPHARMA, INC. reported Shares Outstanding of 27.56 million shares for fiscal year 2025.

CRESCENT BIOPHARMA, INC. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 27.56M +2605.3%
2024 1.02M -98.4%
2023 64.39M +18.4%
2022 54.38M +3.9%
2021 52.31M +6.7%
2020 49.02M +12.8%
2019 43.47M +0.7%
2018 43.16M +25.6%
2017 34.36M +47.8%
2016 23.25M +22.0%
2015 19.05M +0.6%
2014 18.94M +1227.6%
2013 1.43M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 13.89M -78.5% -0.0%
June 30, 2025 13.89M -78.5% -78.5%
March 31, 2025 64.53M +0.1% +6235.3%
December 31, 2024 1.02M -98.4% -98.4%
September 30, 2024 64.48M +0.2% +0.0%
June 30, 2024 64.48M +0.3% +0.1%
March 31, 2024 64.45M +0.3% +0.1%
December 31, 2023 64.39M +18.4% +0.0%
  • CRESCENT BIOPHARMA, INC. showed an increase of +2605.3% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2013–2025 period, CRESCENT BIOPHARMA, INC.’s shares outstanding has grown by 1831.6% (from 1.43 million shares to 27.56 million shares).
  • The most recent figure is from CRESCENT BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment